tiprankstipranks
Trending News
More News >
ASEP Medical Holdings Inc (TSE:ASEP)
:ASEP
Canadian Market

ASEP Medical Holdings Inc (ASEP) Ratios

Compare
7 Followers

ASEP Medical Holdings Inc Ratios

TSE:ASEP's free cash flow for Q3 2024 was C$0.55. For the 2024 fiscal year, TSE:ASEP's free cash flow was decreased by C$ and operating cash flow was C$-12.87. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Dec 20
Liquidity Ratios
Current Ratio
0.25 0.25 6.43 39.90 0.07
Quick Ratio
0.25 0.25 6.43 39.90 0.07
Cash Ratio
0.07 0.07 4.03 36.68 0.05
Solvency Ratio
-2.27 -2.27 -8.47 -14.74 0.00
Operating Cash Flow Ratio
-2.72 -2.72 -6.84 -8.26 -0.14
Short-Term Operating Cash Flow Coverage
-135.63 -135.63 0.00 0.00 -0.16
Net Current Asset Value
C$ -2.80MC$ -2.80MC$ 2.87MC$ 5.61MC$ -150.53K
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.00 0.00 12.82
Debt-to-Equity Ratio
<0.01 <0.01 0.00 0.00 -0.93
Debt-to-Capital Ratio
<0.01 <0.01 0.00 0.00 -14.34
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
2.03 2.03 1.75 1.68 -0.07
Debt Service Coverage Ratio
-401.38 -401.38 -5.50K -19.83 0.00
Interest Coverage Ratio
-28.60K -28.60K -6.69K -19.39 0.00
Debt to Market Cap
<0.01 <0.01 0.00 0.00 <0.01
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
<0.01 <0.01 0.47 2.56 0.00
Profitability Margins
Gross Profit Margin
-538.03%-538.03%0.00%0.00%0.00%
EBIT Margin
-44608.55%-44608.55%0.00%0.00%0.00%
EBITDA Margin
-38486.19%-38486.19%0.00%0.00%0.00%
Operating Profit Margin
-36524.42%-36524.42%0.00%0.00%0.00%
Pretax Profit Margin
-44609.81%-44609.81%0.00%0.00%0.00%
Net Profit Margin
-38918.30%-38918.30%0.00%0.00%0.00%
Continuous Operations Profit Margin
-44609.81%-44609.81%0.00%0.00%0.00%
Net Income Per EBT
87.24%87.24%98.48%98.23%100.00%
EBT Per EBIT
122.14%122.14%107.42%118.50%100.00%
Return on Assets (ROA)
-32.12%-32.12%-21.26%-7.49%-255.89%
Return on Equity (ROE)
-58.60%-65.23%-37.22%-12.61%18.67%
Return on Capital Employed (ROCE)
-31.37%-31.37%-20.50%-6.47%18.67%
Return on Invested Capital (ROIC)
-31.34%-31.34%-20.19%-6.35%286.24%
Return on Tangible Assets
-308.93%-308.93%-166.93%-39.57%-255.89%
Earnings Yield
-41.31%-6.45%-16.01%-0.82%-0.02%
Efficiency Ratios
Receivables Turnover
0.83 0.83 0.00 0.00 0.00
Payables Turnover
0.31 0.31 0.29 1.23 1.27
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.57 0.57 0.00 0.00 0.00
Asset Turnover
<0.01 <0.01 0.00 0.00 0.00
Working Capital Turnover Ratio
0.02 0.02 0.00 0.00 0.00
Cash Conversion Cycle
-720.43 -720.43 -1.24K -297.07 -286.97
Days of Sales Outstanding
438.95 438.95 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
1.16K 1.16K 1.24K 297.07 286.97
Operating Cycle
438.95 438.95 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.04 -0.04 -0.06 -0.02 >-0.01
Free Cash Flow Per Share
-0.04 -0.04 -0.06 -0.02 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.10 1.00
Dividend Paid and CapEx Coverage Ratio
-606.71 -606.71 -8.31K -10.29 0.00
Capital Expenditure Coverage Ratio
-606.71 -606.71 -8.31K -10.29 0.00
Operating Cash Flow Coverage Ratio
-135.63 -135.63 0.00 0.00 -0.16
Operating Cash Flow to Sales Ratio
-128.32 -128.32 0.00 0.00 0.00
Free Cash Flow Yield
-76.33%-2.13%-10.05%-0.47%-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.42 -15.51 -6.25 -121.91 -5.31K
Price-to-Sales (P/S) Ratio
168.38 6.04K 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
1.58 10.12 2.32 15.37 -990.21
Price-to-Free Cash Flow (P/FCF) Ratio
-1.31 -46.96 -9.95 -214.76 -6.74K
Price-to-Operating Cash Flow Ratio
-7.34 -47.03 -9.95 -235.63 -6.74K
Price-to-Earnings Growth (PEG) Ratio
-0.16 -0.52 -0.04 -0.06 -0.67
Price-to-Fair Value
1.58 10.12 2.32 15.37 -990.21
Enterprise Value Multiple
-0.43 -15.68 -7.41 -133.39 0.00
Enterprise Value
3.51M 127.54M 33.84M 275.36M 149.19M
EV to EBITDA
-0.43 -15.68 -7.41 -133.39 0.00
EV to Sales
166.27 6.03K 0.00 0.00 0.00
EV to Free Cash Flow
-1.29 -46.94 -9.36 -210.72 -6.74K
EV to Operating Cash Flow
-1.30 -47.02 -9.36 -231.19 -6.74K
Tangible Book Value Per Share
>-0.01 >-0.01 0.05 0.10 -0.01
Shareholders’ Equity Per Share
0.20 0.20 0.28 0.33 -0.01
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.02 0.02 0.00
Revenue Per Share
<0.01 <0.01 0.00 0.00 0.00
Net Income Per Share
-0.13 -0.13 -0.10 -0.04 >-0.01
Tax Burden
0.87 0.87 0.98 0.98 1.00
Interest Burden
1.00 1.00 1.00 1.05 1.00
Research & Development to Revenue
32.10 32.10 0.00 0.00 0.00
SG&A to Revenue
200.18 200.18 0.00 0.00 0.00
Stock-Based Compensation to Revenue
92.34 92.34 0.00 0.00 0.00
Income Quality
0.33 0.33 0.63 0.51 0.79
Currency in CAD